InsidersTradesSigma
Follow the 씨젠 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 씨젠 has recorded 59 reports. Market capitalisation: €1,464.9bn. The latest transaction was disclosed on 29 April 2026 (Purchase). Among the most active insiders: 최대엽. The full history is accessible without an account.
58
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
50 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 씨젠 Strong Buy (bullish), based on 2 analysts. Average price target: ₩45,500.
Fundamental score
Ranked 8,011 of 29,063 companies
62.7
score / 100
Value59
Quality67
FCF yld7.4%
Earn yld3.3%
EV/EBITDA12.2x
ROE6.5%
Gross mgn64%
Net mgn10%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 April 2026
Declarations59 total
Other
25 of 59 declarations
About 씨젠
씨젠 is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on developing molecular diagnostic solutions.